drugset
drugset / Trial / NCT04015687

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

NCT04015687 ↗

Phase 1 Completed 22 enrolled Agios Pharmaceuticals, Inc.
Non-randomizedSequentialOpen-labelBasic science

Summary

The main purpose of this study is to examine the effect of multiple doses of AG-881 on the pharmacokinetics (PK) of a single dose of lamotrigine in healthy adults.

Timeline

Start
2019-07-15
Primary completion
2019-10-09
Completion
2019-10-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 50 mg Oral
Subject Vorasidenib Small molecule 50 mg Oral

Indications

No indication recorded.